Helicobacter pylori intracellular macromolecules

Helicobacter pylori intracellular macromolecules refers to the collective internal components of the H. pylori bacterium, including DNA, RNA, proteins, and enzymes, that serve as targets for certain antimicrobial agents. This target classification is particularly relevant for drugs like metronidazole and bismuth compounds, which do not interact with a single specific receptor but rather exert their effects by damaging multiple cellular structures or inhibiting various metabolic pathways simultaneously. For instance, metronidazole is reduced within the anaerobic environment of the bacterium to form reactive radicals that cause DNA strand breakage and protein dysfunction. Bismuth salts are thought to act by inhibiting bacterial enzymes, disrupting the cell wall, and causing the leakage of intracellular contents. Targeting these macromolecules is a cornerstone of H. pylori eradication therapy, which is essential for treating peptic ulcers and reducing the risk of gastric adenocarcinoma. However, the increasing prevalence of resistance, particularly to nitroimidazoles, remains a significant therapeutic challenge.

Other names

Bacterial intracellular macromoleculesH. pylori macromoleculesIntracellular components of Helicobacter pylori

Reduction to reactive intermediates that damage DNA and proteins; inhibition of bacterial enzymes and disruption of cell wall/membrane